Filtered By:
Management: Centers for Disease Control and Prevention (CDC)
Countries: USA Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 59 results found since Jan 2013.
A Half-Million Americans May Have Tick-Linked Meat Allergy, C.D.C. Says
Many doctors said that they were unfamiliar with the condition, known as alpha-gal syndrome, the agency found.
Source: NYT Health - July 27, 2023 Category: Consumer Health News Authors: Emily Anthes Tags: your-feed-science your-feed-health Ticks (Insects) Allergies Meat Global Warming Centers for Disease Control and Prevention United States Source Type: news
Delabeling Penicillin Allergy in a Pediatric Primary Care Clinic
Reported adverse drug reactions to penicillins are common, affecting between 10-20% of the North American population; however, more than 90% of patients with a penicillin allergy label can safely tolerate penicillins 1, 2. Numerous adverse outcomes are associated with labeled penicillin allergy 1, 2. In light of this, appropriate diagnosis and verification of a penicillin allergy label is crucial to achieving optimal health outcomes and has been recommended by the Centers for Disease Control and Prevention, the American College of Allergy, Asthma, and Immunology, and the American Academy of Allergy, Asthma, and Immunology 3.
Source: Annals of Allergy, Asthma and Immunology - February 2, 2023 Category: Allergy & Immunology Authors: Timothy G Chow, Gaytri Patel, Mariya Mohammed, Dawn Johnson, David A. Khan Tags: Letters Source Type: research
To thwart the next pandemic, ‘swientists’ hunt for flu viruses at U.S. hog shows
.news-article__hero--featured .parallax__element { object-position: 10% 60%; -o-object-position: 10% 60%; } @media (max-width: 991.98px) { .news-article__hero--featured .parallax:before { background: linear-gradient(180deg, rgba(0, 0, 0, 90%), transparent 50%, transparent 85%, rgba(0, 0, 0, 60%) 100%); } .news-article__hero--featured .news-article__hero__info-wrapper { height: 100%; } .news-article__hero--featured .news-article__hero__scroller { bottom: 0; position: absolute; left: calc(50% - 50px); } .parallax__element {} } @media (min-width: 992px) { .news-article__hero--featured .parallax:before { ...
Source: ScienceNOW - October 27, 2022 Category: Science Source Type: news
U.S. weighs crackdown on experiments that could make viruses more dangerous
.news-article__hero--featured .parallax__element{ object-position: 50% 40%; -o-object-position: 50% 40%; } .scroll-wrapper { overflow-x: auto; } .scroll-wrapper .news-article__figure__image{ width: 2680px; max-width: none; padding-bottom: .75rem; } .scroll-fade-before, .scroll-fade-after { position: absolute; width: 1.5rem; transition-duration: .1s; opacity: 1; } .scroll-fade-before { left: 1rem; /*margin-left: -1px;*/ background: linear-gradient(90deg, #fff, #fff 35%, hsla(0, 0%, 100%, 0)); } .scroll-fade-after { right: 1rem; /*margin-right: -1px;*/ background: linear-gradient(270deg, #fff, #fff 35%, hsla(0,...
Source: ScienceNOW - October 19, 2022 Category: Science Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I'm not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
Anthony Fauci, loved and hated, plots his next move: ‘I’m not going to sit in my house’
In 1984, when Anthony Fauci took over as head of the National Institute of Allergy and Infectious Diseases (NIAID), his wife gave him a plant for the new office. Both the palm and the 81-year-old physician are still there, the giant plant now crowding the office of one of the most celebrated—and polarizing—scientific figures in U.S. history. But not for much longer. Fauci announced on 22 August that he would step down at the end of the year from both NIAID and his post as the chief medical adviser to President Joe Biden.
“What am I going to do with this plant? It’s a monster. I can’t fit it in any other plac...
Source: ScienceNOW - September 1, 2022 Category: Science Source Type: news
There ’s a shortage of monkeypox vaccine. Could one dose instead of two suffice?
As the monkeypox outbreak grows, the preferred vaccine to combat it is in short supply—a problem that’s only getting worse now that countries are expanding access to the vaccine. But there is a strategy that could double overnight the number of people who can be vaccinated: use a single shot instead of the recommended two.
Compelling data from monkey and human studies suggest a single dose of the vaccine—produced by Bavarian Nordic and sold under three different brand names—solidly protects against monkeypox, and that the second dose mainly serves to extend the durability of protection.
The United Kingdom...
Source: Science of Aging Knowledge Environment - July 1, 2022 Category: Geriatrics Source Type: research
News at a glance: China ’s carbon pledge, ARPA-H’s interim head, and an exascale computer
Some content has been removed for formatting reasons. Please view the original article for the best reading experience.
Table of contents
A version of this story appeared in Science, Vol 376, Issue 6597.
Download PDF
CONSERVATION
U.S. moves to stop Alaska copper mine
The U.S. Environmental Protection Agency (EPA) is moving to block construction of a massive copper and gold mine that would risk polluting the headwaters of Alaska’s Bristol Bay, home to the world’s largest sockeye salmon runs. EPA announced last week it plans to forbid dis...
Source: Science of Aging Knowledge Environment - June 2, 2022 Category: Geriatrics Source Type: research
Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine
NEW BRUNSWICK, N.J., December 15, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a Positive Opinion for use of the Company’s COVID-19 vaccine as a booster for adults aged 18 and older at least two months after primary vaccination with a single-shot of the Johnson & Johnson COVID-19 vaccine, and as a ‘mix and match’ booster following primary vaccination with an approved two-shot mRNA COVID-19 vaccine regimen (known as heterologous boosting). “We are pleased with today’s Positiv...
Source: Johnson and Johnson - December 15, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day.
The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
CDC Authorizes Boosters of Moderna and Johnson & Johnson COVID-19 Vaccines
Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), authorized booster doses of COVID-19 vaccines for certain groups. Walensky followed the advice of a CDC expert panel, which recommended the boosters in in two unanimous votes earlier in the day.
The 15-member Advisory Committee on Immunization Practices (ACIP) advised that anyone who was initially vaccinated with the Moderna shot get a booster at least six months later, and that J&J-Janssen recipients receive a booster at least two months after their initial vaccination. The endorsement follows a similar decision from the Food and ...
Source: TIME: Health - October 21, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news
The CDC Turns Its Back on Migrants and Science
Credit: UNOHCR.By Jamile Tellez Lieberman and Joe AmonPHILADELPHIA, US, Oct 7 2021 (IPS) Last month, asylum-seeking families at the U.S.-Mexico border appeared to have won a victory, however temporary, in their last-ditch bid for safety in the United States. It was also a victory for evidence-based public health policy.
The 1,954-mile-long southern border has always been a magnet for debate, with deep political divides. Bolstered by Donald Trump during his presidency, long-simmering anti-immigrant rhetoric and xenophobia surrounding migration and immigration increased dramatically.
Starting in 2016, under the previous admi...
Source: IPS Inter Press Service - Health - October 7, 2021 Category: International Medicine & Public Health Authors: Jamile Tellez Lieberman and Joe Amon Tags: Headlines Health Human Rights Migration & Refugees North America TerraViva United Nations Source Type: news
Maternal COVID-19, vaccination safety in pregnancy, and evidence of protective immunity
Over the past 18 months, the world has seen the largest pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 28, 2021, the Centers for Disease Control and Prevention (CDC) reported 98,948 cases of coronavirus disease 2019 (COVID-19) infection in pregnancy and 109 related maternal deaths in the United States alone.1 As the pandemic continues to evolve, the rapid and overwhelming increase in available evidence on the impact in pregnancy has resulted in studies of varying degrees of bias and quality.
Source: Journal of Allergy and Clinical Immunology - July 24, 2021 Category: Allergy & Immunology Authors: Amelie Pham, David M. Aronoff, Jennifer L. Thompson Tags: COVID-19 Source Type: research
We Used to Have a Lyme Disease Vaccine. Are We Ready to Bring One Back?
At my animal hospital in upstate New York, an epicenter of the U.S. tick epidemic, my dog Fawn lets out a whimper as the veterinarian injects her with her annual Lyme disease shot. I roll my eyes. She doesn’t know how good she has it.
The injection means that if a tick bites her (and in rural New York, a tick always does), the creepy crawly will feast on dog blood that’s been supercharged with a Lyme bacteria-killing substance, and Lyme disease won’t be transmitted to Fawn.
I wish I could be shot up with that superpower. Currently, there is no human vaccine for Lyme disease—even though more than two...
Source: TIME: Health - June 17, 2021 Category: Consumer Health News Authors: Mandy Oaklander Tags: Uncategorized Disease feature Source Type: news
Johnson & Johnson Single-Shot COVID-19 Vaccine Phase 3 Data Published in New England Journal of Medicine
NEW BRUNSWICK, N.J., April 21, 2021 – Johnson & Johnson (the Company) today announced publication in the New England Journal of Medicine of primary data from the Phase 3 ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The publication of the primary analysis follows the topline efficacy and safety data announced in January, showing the trial met all primary and key secondary endpoints, and found that the Johnson & Johnson single-dose COVID-19 vaccine prevented hospitalization and death across all study participants ...
Source: Johnson and Johnson - April 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news
